Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premal D Lulla

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Blood|March 3, 2022
CAR T cells and autologous transplantation can coexist for DLBCLPremal D Lulla
Cancer Journal (Sudbury, Mass.)|January 24, 2023
Emerging Challenges to Cellular Therapy of CancerPremal D Lulla, Malcolm Brenner
Blood|January 6, 2022
COVID-specific T's may offset therapeutically endangered B'sLaQuisa C Hill, Premal D Lulla
Cancer Journal (Sudbury, Mass.)|May 29, 2019
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic LeukemiaPremal D Lulla, Maksim Mamonkin, Malcolm K Brenner
Journal of Gastrointestinal Cancer|October 12, 2012
Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenibPremal D Lulla, Jonathan E Brammer, Salman Bandeali, et al.
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphomaPremal D Lulla, LaQuisa C Hill, Carlos A Ramos, et al.
Cytotherapy|December 27, 2023
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapyChiraag D Kapadia, Gerardo Rosas, Sachin G Thakkar, et al.
Nature Medicine|January 2, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trialBenjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo, et al.
Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.
Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood|March 3, 2022
CAR T cells and autologous transplantation can coexist for DLBCLPremal D Lulla
Cancer Journal (Sudbury, Mass.)|January 24, 2023
Emerging Challenges to Cellular Therapy of CancerPremal D Lulla, Malcolm Brenner
Blood|January 6, 2022
COVID-specific T's may offset therapeutically endangered B'sLaQuisa C Hill, Premal D Lulla
Cancer Journal (Sudbury, Mass.)|May 29, 2019
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic LeukemiaPremal D Lulla, Maksim Mamonkin, Malcolm K Brenner
Journal of Gastrointestinal Cancer|October 12, 2012
Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenibPremal D Lulla, Jonathan E Brammer, Salman Bandeali, et al.
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphomaPremal D Lulla, LaQuisa C Hill, Carlos A Ramos, et al.
Cytotherapy|December 27, 2023
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapyChiraag D Kapadia, Gerardo Rosas, Sachin G Thakkar, et al.
Nature Medicine|January 2, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trialBenjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo, et al.
Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.
Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.
Pageof 2